Developmental Dysplasia of the Hip.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 2019
Historique:
accepted: 07 09 2018
pubmed: 28 12 2018
medline: 16 10 2019
entrez: 28 12 2018
Statut: ppublish

Résumé

Pediatricians are often the first to identify developmental dysplasia of the hip (DDH) and direct subsequent appropriate treatment. The general treatment principle of DDH is to obtain and maintain a concentric reduction of the femoral head in the acetabulum. Achieving this goal can range from less-invasive bracing treatments to more-invasive surgical treatment depending on the age and complexity of the dysplasia. In this review, we summarize the current trends and treatment principles in the diagnosis and treatment of DDH.

Identifiants

pubmed: 30587534
pii: peds.2018-1147
doi: 10.1542/peds.2018-1147
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Auteurs

Scott Yang (S)

Department of Orthopedics and Rehabilitation, Doernbecher Children's Hospital and Oregon Health and Science University, Portland, Oregon; and yansc@ohsu.edu.

Natalie Zusman (N)

Department of Orthopedics and Rehabilitation, Doernbecher Children's Hospital and Oregon Health and Science University, Portland, Oregon; and.

Elizabeth Lieberman (E)

Department of Orthopedics and Rehabilitation, Doernbecher Children's Hospital and Oregon Health and Science University, Portland, Oregon; and.

Rachel Y Goldstein (RY)

Children's Orthopaedic Center, Children's Hospital Los Angeles, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH